TrialProstate cancer and prostatic diseases2013

RTOG 0518: randomized phase III trial to evaluate zoledronic acid for prevention of osteoporosis and associated fractures in prostate cancer patients.

L A Kachnic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.